๐ŸŽ Black Friday: up to 50% off of annual plans
Apex Biotechnology Corp. (TPE:1733)
Taiwan flag Taiwan ยท Delayed Price ยท Currency is TWD
28.00
-0.70 (-2.44%)
Nov 20, 2026, 1:30 PM CST

Apex Biotechnology Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,8581,9451,8521,6772,2442,132
Revenue Growth
-5.22%5.00%10.48%-25.29%5.28%6.30%
Gross Profit
591.49538.74521.34531.12576.84571.51
Operating Income
190.51140.73128.46141.72176.56204.95
Net Income
185.61162.89128115.78181.79202.22
Earnings Per Share
1.851.621.271.151.811.93
EPS Growth
23.39%27.56%10.44%-36.46%-6.16%120.97%

Revenue by Geography

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States
885.18715.86683.99898.35912.27
Italy
535.58568.53537.88661.25740.2
Austria
276.07245.12142.14365.42146.12
Taiwan
75.8677.3773.8593.4771.42
Others
149.16211.04190.85170.57212.29
Mainland China
23.0634.2947.8355.1249.35
Total
1,9451,8521,6772,2442,132

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
590.02644.37598.78443.91397.53625.05
Total Debt
117.06109.67122.96153.4180.68284.55
Net Cash (Debt)
472.96534.69475.83290.52216.85340.5
Net Cash Growth
5.19%12.37%63.79%33.97%-36.31%10.11%
Net Cash Per Share
4.725.324.742.902.153.22

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
186.29160.12328.67230.3926.62179.87
Capital Expenditures
-15.26-15.26-28.24-21.91-36.58-26.59
Free Cash Flow
171.03144.86300.43208.48-9.97153.28
Free Cash Flow Growth
-20.57%-51.78%44.10%---34.87%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
31.84%27.70%28.15%31.68%25.70%26.81%
Operating Margin
10.26%7.24%6.94%8.45%7.87%9.62%
Pretax Margin
11.30%9.76%8.27%8.41%8.89%8.68%
Profit Margin
9.99%8.38%6.91%6.91%8.10%9.49%
FCF Margin
9.21%7.45%16.22%12.44%-0.44%7.19%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.3001.3001.2001.1001.4001.300
Dividend Per Share Growth
8.33%8.33%9.09%-21.43%7.69%18.18%
Dividend Yield
4.64%4.27%3.99%2.73%5.48%5.00%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
15.1318.6823.5034.7914.0512.85
Forward PE
-13.1113.1113.1113.1113.11
P/FCF Ratio
16.3621.0110.0119.32-16.95
PS Ratio
1.511.571.622.401.141.22